Development of congenital Zika syndrome is likely multifactorial and symptoms such as microcephaly, which is only one disease manifestation (Aliota et al., 2017), are unlikely to be the consequence of FMRP inhibition. The gene discussed is FMR1; the disease is microcephaly.